Dermatologic Implications of COVID-19 Infection and Immunization: Hair Loss

August 2024 in “ Journal of Dermatology for Physician Assistants ”

Nicole Bielecki

hair loss COVID-19 alopecia trichopsychodermatology viral illness medications nutritional deficiencies hair thinning stress-related hair loss

TLDR Early treatment of COVID-19-related hair loss is crucial for better outcomes.

The article reviews the treatment of hair loss induced by COVID-19 infection and immunization, emphasizing the importance of early identification and treatment to improve patient outcomes. The review utilized the PubMed database, focusing on studies published within the last 5 years, and identified 40 relevant results. The research highlights the psychological impact of hair loss and the emerging field of trichopsychodermatology. It calls for further investigation to determine whether COVID-19–induced alopecia is due to physical and emotional stress, the viral illness itself, medications used for treatment, or nutritional deficiencies.

View this study on journals.lww.com →

Discuss this study in the Community →

Research cited in this study

12 / 12 results

research Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases

May 2023 in “Journal of Clinical Medicine”

New understanding and treatments for hair loss are improving, but more research is needed.

research Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies

3 citations, August 2022 in “International Journal of Molecular Sciences”

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

research Characteristics of Hair Loss After COVID-19: A Systematic Scoping Review

12 citations, July 2022 in “Journal of Cosmetic Dermatology”

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.

Management of Hair Loss After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Insight Into the Pathophysiology With Implication for Better Management

research Management of Hair Loss After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Insight Into the Pathophysiology With Implication for Better Management

7 citations, May 2022 in “The Journal of Dermatology”

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

research Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium

3 citations, April 2022 in “Clinical, Cosmetic and Investigational Dermatology”

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

research Evaluation of Patients with Telogen Effluvium During the Pandemic: Are Monocytes Responsible for Post COVID-19 Telogen Effluvium?

4 citations, February 2022 in “Journal of Cosmetic Dermatology”

Monocytes might be linked to hair loss after COVID-19.

research Covid Induced Telogen Effluvium: An Insight

4 citations, January 2022 in “Indian Dermatology Online Journal”

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

research COVID-19 Induced Telogen Effluvium

22 citations, October 2021 in “Dermatologic Therapy”

COVID-19 may cause temporary hair loss in some people.

research COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium

25 citations, August 2021 in “Irish Journal of Medical Science (1971 -)”

COVID-19 infection can significantly cause temporary hair loss.

Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

39 citations, August 2021 in “JAAD International”

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

research Minoxidil: A Comprehensive Review

16 citations, June 2021 in “Journal of Dermatological Treatment”

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

research Low-Dose Oral Minoxidil as Treatment for Non-Scarring Alopecia: A Systematic Review

19 citations, June 2020 in “International Journal of Dermatology”

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Related Research

4 / 4 results

research Alopecia Areata: A Multifactorial Autoimmune Condition

148 citations, December 2018 in “Journal of autoimmunity”

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

research Linear Alopecia Areata

4 citations, November 2018 in “JAAD case reports”

Alopecia areata can sometimes appear as a straight line of hair loss instead of round patches.

research Treating Resistant Cases of Alopecia Universalis

May 2018 in “Journal of cosmetology & trichology”

Combining platelet-rich plasma therapy with prostaglandin-F eye drops can significantly regrow hair in alopecia universalis.

research Overview of Alopecia Areata

110 citations, December 2013 in “The journal of investigative dermatology. Symposium proceedings/The Journal of investigative dermatology symposium proceedings”

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.